Khalil Zaman
- Oncology top 2%
- Molecular Biology
- Cancer Research top 5%
- Pulmonary and Respiratory Medicine top 10%
- Genetics top 10%
- Co-authors
- Serge LeyvrazLaurent A. DécosterdMaryse FicheNicolas WidmerChantal CsajkaBertrand RochatBoris ZanolariThierry Buclin
- Topics
- Cancer Treatment and Pharmacology (27 papers)HER2/EGFR in Cancer Research (26 papers)Breast Cancer Treatment Studies (22 papers)
- Cited by
- OncologyCancer ResearchHematology
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Khalil Zaman
87 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 116
- Oncology 991
- Molecular Biology 483
- Cancer Research 476
- Pulmonary and Respiratory Medicine 379
- Genetics 240
Countries citing papers authored by Khalil Zaman
This map shows the geographic impact of Khalil Zaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Zaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Zaman more than expected).
Fields of papers citing papers by Khalil Zaman
This network shows the impact of papers produced by Khalil Zaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Zaman. The network helps show where Khalil Zaman may publish in the future.
Co-authorship network of co-authors of Khalil Zaman
This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Zaman. A scholar is included among the top collaborators of Khalil Zaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Zaman. Khalil Zaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 28 | |
| 4 | 0 | |
| 5 | 0 | |
| 6 | 9 | |
| 7 | 0 | |
| 8 | 6 | |
| 9 | 58 | |
| 10 | 3 | |
| 11 | 18 | |
| 12 | 45 | |
| 13 | 7 | |
| 14 | 27 | |
| 15 | 2 | |
| 16 | 56 | |
| 17 | 45 | |
| 18 | 61 | |
| 19 | 28 | |
| 20 | 1 |
About Khalil Zaman
Khalil Zaman is a scholar working on Oncology, Cancer Research and Family Practice, having authored 100 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (27 papers), HER2/EGFR in Cancer Research (26 papers) and Breast Cancer Treatment Studies (22 papers). The work is most often cited by research in Oncology (991 citations), Cancer Research (476 citations) and Hematology (152 citations). Khalil Zaman has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Serge Leyvraz, Laurent A. Décosterd, Maryse Fiche, Nicolas Widmer, Chantal Csajka, Bertrand Rochat, Boris Zanolari, Thierry Buclin, Michel A. Duchosal and Amina Haouala. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.